Understanding One-and-a-Half Syndrome
One-and-a-Half Syndrome, also known as “INO Plus,” is a neurological condition that arises from damage to the medial longitudinal fasciculus nerve. In addition to this damage, the abducens nucleus or the paramedian pontine reticular formation (PPRF) in the brain may also be affected. The abducens nucleus is a cranial nerve nucleus responsible for controlling horizontal eye movements, while the PPRF aids in coordinating these horizontal movements and saccades – the quick, small eye movements that occur during activities like reading.
In individuals with normal vision, as one eye moves towards the center of the face (adducts), the other eye moves away from the center (abducts) – for example, when glancing to the left. However, one-and-a-half syndrome disrupts this synchronized movement. This condition is commonly associated with multiple sclerosis, tumors, or vascular diseases, similar to INO.
Understanding Myasthenia Gravis
Myasthenia gravis is a chronic autoimmune neuromuscular disease that often manifests with early eye symptoms. These symptoms, which may include diplopia (double vision) and ophthalmoplegia (weakness or paralysis of eye muscles), are sometimes the only initial signs of the condition. Additionally, one or both eyelids may experience ptosis, or drooping. As the disease progresses, individuals may also experience difficulty swallowing and slurred speech. While myasthenia gravis is rare in infants, it is possible for a fetus to acquire antibodies from a mother with the condition. Thankfully, these symptoms typically resolve within two to three months after birth. Although a cure for myasthenia gravis has yet to be discovered, there are effective treatment options available.